TW200514553A - Therapeutic agent for hepatitis C - Google Patents

Therapeutic agent for hepatitis C

Info

Publication number
TW200514553A
TW200514553A TW093130063A TW93130063A TW200514553A TW 200514553 A TW200514553 A TW 200514553A TW 093130063 A TW093130063 A TW 093130063A TW 93130063 A TW93130063 A TW 93130063A TW 200514553 A TW200514553 A TW 200514553A
Authority
TW
Taiwan
Prior art keywords
hepatitis
therapeutic agent
agent
salt
compound
Prior art date
Application number
TW093130063A
Other languages
Chinese (zh)
Inventor
Kunitada Shimotono
Michinori Kohara
Original Assignee
Fujisawa Pharmaceutical Co
Tokyo Metropolitan Org Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co, Tokyo Metropolitan Org Med Res filed Critical Fujisawa Pharmaceutical Co
Publication of TW200514553A publication Critical patent/TW200514553A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

This invention provides a prophylactic agent and/or therapeutic agent for hepatitis C, which comprises a compound of formula (I) or a salt thereof as an active ingredient.
TW093130063A 2003-10-06 2004-10-05 Therapeutic agent for hepatitis C TW200514553A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003346891A JP2007015926A (en) 2003-10-06 2003-10-06 Therapeutic agent for hepatitis c

Publications (1)

Publication Number Publication Date
TW200514553A true TW200514553A (en) 2005-05-01

Family

ID=34419565

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093130063A TW200514553A (en) 2003-10-06 2004-10-05 Therapeutic agent for hepatitis C

Country Status (3)

Country Link
JP (1) JP2007015926A (en)
TW (1) TW200514553A (en)
WO (1) WO2005032576A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696167B2 (en) 2004-11-22 2010-04-13 Astellas Pharma Inc. Cyclic peptide compound
CA2623898C (en) * 2005-10-26 2013-12-24 Astellas Pharma Inc. New cyclic peptide compounds
CN101687012A (en) * 2007-05-02 2010-03-31 安斯泰来制药有限公司 New cyclic peptide compounds
US20110158908A1 (en) 2007-08-24 2011-06-30 Sapporo Medical University Cyclosporin a-binding protein
JP5625910B2 (en) * 2008-09-24 2014-11-19 アステラス製薬株式会社 Peptide compound and method for producing the same
CN102559930A (en) * 2012-01-16 2012-07-11 中山大学达安基因股份有限公司 Kit of detecting hepahtis C virus by fluorescence quantitative RT-PCR (reverse transcription-polymerase chain reaction)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1372695A2 (en) * 2000-10-19 2004-01-02 Fujisawa Pharmaceutical Co., Ltd. Cell damage inhibitor

Also Published As

Publication number Publication date
JP2007015926A (en) 2007-01-25
WO2005032576A1 (en) 2005-04-14

Similar Documents

Publication Publication Date Title
MXPA06000013A (en) Therapeutic agent for soft tissue sarcoma.
DE602004021472D1 (en) Pyrimiidinverbindungen
WO2004004657A3 (en) Hiv integrase inhibitors
NO20072058L (en) Inhibitors of the interaction between MDM2 and P53
NO20050525L (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
GB0124627D0 (en) Novel compounds
AU2003228770A8 (en) Substituted pyrazolopyrimidines
UA91002C2 (en) 7-phenylalkyl substituted 2-quinolinones and 2- quinoxalinones as poly(adp-polymerase inhibitors
WO2005085236A3 (en) Caspase inhibitors and uses thereof
MXPA04003886A (en) Thiopene- amd thiazolesulfonamides as antineoplastic agents.
MXPA05012837A (en) Caspase inhibitors and uses thereof.
DK1456212T3 (en) 6-aminomorphinan derivatives, processes for their preparation and their use
MXPA05011176A (en) Carboxamide derivatives as anti-diabetic agents.
MXPA04006041A (en) Pyridoquinoxaline antivirals.
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
TW200514553A (en) Therapeutic agent for hepatitis C
GB0308201D0 (en) Novel compounds
WO2004087652A3 (en) Imidazotriazine compounds
DE60201074D1 (en) Pyrazolopyridinderivate
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
MXPA04005151A (en) Therapeutic compounds.
TW200519126A (en) An antibacterial agent a against propionibacterium acnes
TW200640464A (en) Pharmaceutical composition comprising phenoxazinium compounds as an active ingredient
TW200420561A (en) Antimicrobial 1-aryl dihydropyridone compounds
TW200505872A (en) Hepatitis C virus inhibitors